8Ohg Qed Bioscience Antibody

Description: JBS True Blue

Description: Recombinant anti-TFR (Transferrin Receptor), which recognizes TFR. The purified antibody was enzymatically biotinylated using Avi-tag^TM technology. This affinity purified antibody has been tested for specific binding to purified human TFR1 (BPS Bioscience #101287) in an ELISA binding assay.

Description: Biotinylated anti-CD20 IgG antibody is a purified recombinant antibody which recognizes human CD20 antigen. This antibody has been tested for specific binding to purified human CD20 protein.

Description: Biotinylated anti-CD20 IgG antibody is a purified recombinant antibody which recognizes human CD20 antigen. This antibody has been tested for specific binding to purified human CD20 protein.

Description: This anti-CD19 IgG antibody is a purified recombinant antibody, which was enzymatically biotinylated using Avi-tag™ technology. This antibody has been tested for specific binding to purified human CD19 protein (BPS Bioscience #101015).

Description: This anti-CD19 IgG antibody is a purified recombinant antibody, which was enzymatically biotinylated using Avi-tag™ technology. This antibody has been tested for specific binding to purified human CD19 protein (BPS Bioscience #101015).

Description: Biotinylated anti-CD123 IgG antibody is a purified recombinant antibody that recognizes human CD123 antigen. This antibody has been tested for specific binding affinity to purified human CD123 protein.

Description: Biotinylated anti-CD123 IgG antibody is a purified recombinant antibody that recognizes human CD123 antigen. This antibody has been tested for specific binding affinity to purified human CD123 protein.

Description: Anti-CD235a antibody is a purified biotinylated recombinant human antibody which recognizes the CD235a/GYPA protein. This antibody has been tested for specific binding to purified human CD235a protein (BPS Bioscience #101196) in a colorimetric ELISA binding assay. This protein is enzymatically biotinylated using Avi-Tag™ technology. Biotinylation is confirmed to be ≥90%.

Description: This anti-NCAM1 (CD56) IgG is a purified recombinant antibody, which was enzymatically biotinylated using Avi-tag™ technology. This antibody has been tested for specific binding affinity to purified human NCAM1 (aka CD56) protein (BPS Bioscience #101043).

Description: This anti-FcGR3A (CD16A) antibody is a purified, biotinylated, recombinant human monoclonal antibody which recognizes the human FcGR3A/CD16A protein. Fc Gamma Receptor IIIa (FcGRIIIA; FcγRIIIA), also known as CD16a, is a low/intermediate affinity receptor for polyvalent immune-complexed IgG. It is involved in phagocytosis, antibody-dependent cytotoxicity, and clearance of immune complexes.  FcGR3A/CD16A plays a role in the activation of natural killer (NK) cells. Clinically, it serves as a marker of certain immune cells such as neutrophils. CD16 expression has been observed at the surface of T cells in patients with chronic viral infections (such as COVID-19). It is considered a potential therapeutic target to potentiate the efficacy of therapeutic antibodies used to treat solid tumors, or as direct target in hematopoietic cancers._x000D_This antibody has been tested for specific binding to purified human FcGR3A/CD16A (BPS Bioscience #79013) in an ELISA binding assay with colorimetric detection. It does not cross-react with purified human FcGR2B/CD16B.

Description: This anti-FcGR3A (CD16A) antibody is a purified, biotinylated, recombinant human monoclonal antibody which recognizes the human FcGR3A/CD16A protein. Fc Gamma Receptor IIIa (FcGRIIIA; FcγRIIIA), also known as CD16a, is a low/intermediate affinity receptor for polyvalent immune-complexed IgG. It is involved in phagocytosis, antibody-dependent cytotoxicity, and clearance of immune complexes.  FcGR3A/CD16A plays a role in the activation of natural killer (NK) cells. Clinically, it serves as a marker of certain immune cells such as neutrophils. CD16 expression has been observed at the surface of T cells in patients with chronic viral infections (such as COVID-19). It is considered a potential therapeutic target to potentiate the efficacy of therapeutic antibodies used to treat solid tumors, or as direct target in hematopoietic cancers._x000D_This antibody has been tested for specific binding to purified human FcGR3A/CD16A (BPS Bioscience #79013) in an ELISA binding assay with colorimetric detection. It does not cross-react with purified human FcGR2B/CD16B.

Description: Purified, recombinant, human anti-PD-1 (IgG1) antibody with C-terminal Avitag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species.

Description: Purified, recombinant, chimeric murine/human anti-PD-L1 (IgG1) antibody with C-terminal Avi-tag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody reacts with human PD-L1 and cross-reacts with mouse PD-L1. It has not been tested for cross-reactivity with other species.

Description: Purified recombinant human_x000D_anti-PCSK9 (IgG1) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This antibody reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species.

Description: Purified recombinant human_x000D_anti-PCSK9 (IgG4) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This protein reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species.

Description: Biotinylated anti-Claudin-18 isoform 2 (CLDN18.2) IgG1 antibody is a purified recombinant antibody that recognizes human CLDN18.2 antigen. This antibody has been tested for specific binding to purified human CLDN18.2 protein.